• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酰胺质子转移加权磁共振成像在头颈部良恶性肿瘤鉴别诊断中的应用。

Differentiation of Malignant and Benign Head and Neck Tumors with Amide Proton Transfer-Weighted MR Imaging.

机构信息

Department of Radiology, Beijing Hospital, National Center of Gerontology, No. 1 Da-Hua Road, Dong Dan, Beijing, 100730, China.

Graduate School of Peking Union Medical College, No. 9 Dong Dan San Tiao, Beijing, 100730, China.

出版信息

Mol Imaging Biol. 2019 Apr;21(2):348-355. doi: 10.1007/s11307-018-1248-1.

DOI:10.1007/s11307-018-1248-1
PMID:29987616
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6467531/
Abstract

PURPOSE

To prospectively evaluate the feasibility and capability of amide proton transfer-weighted (APTw) imaging for the characterization of head and neck tumors.

PROCEDURES

Twenty-nine consecutive patients with suspected head and neck tumors were enrolled in this study and underwent APTw magnetic resonance imaging (MRI) on a 3.0-T MRI scanner. The patients were divided into malignant (n = 16) and benign (n = 13) groups, based on pathological results. A map of magnetization transfer ratio asymmetry at 3.5 ppm [MTR (3.5 ppm)] was generated for each patient. Interobserver agreement was evaluated and comparisons of MTR (3.5 ppm) were made between the malignant and benign groups. Receiver operating characteristic analysis was used to determine the appropriate threshold value of MTR (3.5 ppm) for the differentiation of malignant from benign tumors.

RESULTS

The intraclass correlation coefficients of the malignant and benign groups were 0.96 and 0.90, respectively, which indicated a good interobserver agreement. MTR (3.5 ppm) was significantly higher for the malignant group (3.66 ± 1.15 %) than for the benign group (1.94 ± 0.93 %, P < 0.001). APTw MRI revealed an area under the curve of 0.904 in discriminating these two groups, with a sensitivity of 81.3 %, a specificity of 92.3 %, and an accuracy of 86.2 %, at the threshold of 2.62 % of MTR (3.5 ppm).

CONCLUSIONS

APTw MRI is feasible for use in the head and neck tumors and is a valuable imaging biomarker for distinguishing malignant from benign lesions.

摘要

目的

前瞻性评估酰胺质子转移加权(APTw)成像对头颈部肿瘤特征描述的可行性和能力。

方法

本研究纳入 29 例疑似头颈部肿瘤患者,并在 3.0T MRI 扫描仪上进行 APTw 磁共振成像(MRI)。根据病理结果,将患者分为恶性(n=16)和良性(n=13)两组。为每位患者生成一个 3.5ppm 处磁化转移率不对称图[MTR(3.5ppm)]。评估了观察者间的一致性,并比较了恶性和良性组之间的 MTR(3.5ppm)。使用受试者工作特征分析确定 MTR(3.5ppm)区分良恶性肿瘤的合适阈值。

结果

恶性和良性组的组内相关系数分别为 0.96 和 0.90,表明观察者间具有良好的一致性。恶性组的 MTR(3.5ppm)(3.66±1.15%)明显高于良性组(1.94±0.93%,P<0.001)。APTw MRI 在区分这两组时,曲线下面积为 0.904,灵敏度为 81.3%,特异性为 92.3%,准确性为 86.2%,MTR(3.5ppm)阈值为 2.62%。

结论

APTw MRI 对头颈部肿瘤是可行的,是区分良恶性病变的有价值的成像生物标志物。

相似文献

1
Differentiation of Malignant and Benign Head and Neck Tumors with Amide Proton Transfer-Weighted MR Imaging.酰胺质子转移加权磁共振成像在头颈部良恶性肿瘤鉴别诊断中的应用。
Mol Imaging Biol. 2019 Apr;21(2):348-355. doi: 10.1007/s11307-018-1248-1.
2
Amide proton transfer-weighted imaging to differentiate malignant from benign pulmonary lesions: Comparison with diffusion-weighted imaging and FDG-PET/CT.酰胺质子转移加权成像鉴别良恶性肺病变:与弥散加权成像和 FDG-PET/CT 的比较。
J Magn Reson Imaging. 2018 Apr;47(4):1013-1021. doi: 10.1002/jmri.25832. Epub 2017 Aug 11.
3
Amide proton transfer-weighted imaging of the head and neck at 3 T: a feasibility study on healthy human subjects and patients with head and neck cancer.3T 下头部和颈部的酰胺质子转移加权成像:对健康人体受试者和头颈癌患者的可行性研究
NMR Biomed. 2014 Oct;27(10):1239-47. doi: 10.1002/nbm.3184. Epub 2014 Aug 19.
4
A Comparative Study of Amide Proton Transfer Weighted Imaging and Intravoxel Incoherent Motion MRI Techniques Versus (18) F-FDG PET to Distinguish Solitary Pulmonary Lesions and Their Subtypes.酰胺质子转移加权成像与体素内不相干运动 MRI 技术与 (18) F-FDG PET 对比鉴别孤立性肺病变及其亚型的研究
J Magn Reson Imaging. 2022 May;55(5):1376-1390. doi: 10.1002/jmri.27977. Epub 2021 Nov 1.
5
Amide proton transfer-weighted MRI for renal tumors: Comparison with diffusion-weighted imaging.酰胺质子转移加权磁共振成像在肾肿瘤中的应用:与弥散加权成像的比较。
Magn Reson Imaging. 2024 Feb;106:104-109. doi: 10.1016/j.mri.2023.12.002. Epub 2023 Dec 21.
6
Amide Proton Transfer-weighted MRI in the Diagnosis of Major Salivary Gland Tumors.酰胺质子转移加权磁共振成像在大唾液腺肿瘤诊断中的应用。
Sci Rep. 2019 Jun 6;9(1):8349. doi: 10.1038/s41598-019-44820-0.
7
Non-invasive Differentiation of Endometrial Adenocarcinoma from Benign Lesions in the Uterus by Utilization of Amide Proton Transfer-Weighted MRI.酰胺质子转移加权磁共振成像在子宫良性病变与子宫内膜腺癌的无创鉴别诊断中的应用
Mol Imaging Biol. 2021 Jun;23(3):446-455. doi: 10.1007/s11307-020-01565-x. Epub 2020 Nov 13.
8
Comparative Study of Amide Proton Transfer-Weighted Imaging and Intravoxel Incoherent Motion Imaging in Breast Cancer Diagnosis and Evaluation.酰胺质子转移加权成像与体素内不相干运动成像在乳腺癌诊断及评估中的对比研究
J Magn Reson Imaging. 2020 Oct;52(4):1175-1186. doi: 10.1002/jmri.27190. Epub 2020 May 5.
9
Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla.在3特斯拉磁场下,使用基于内源性蛋白质的酰胺质子转移磁共振成像对原发性中枢神经系统淋巴瘤和高级别胶质瘤进行分子磁共振成像鉴别
Eur Radiol. 2016 Jan;26(1):64-71. doi: 10.1007/s00330-015-3805-1. Epub 2015 Apr 30.
10
Differentiation of fibroadenomas versus malignant breast tumors utilizing three-dimensional amide proton transfer weighted magnetic resonance imaging.利用三维酰胺质子转移加权磁共振成像鉴别纤维腺瘤与恶性乳腺肿瘤。
Clin Imaging. 2022 Jan;81:15-23. doi: 10.1016/j.clinimag.2021.09.002. Epub 2021 Sep 25.

引用本文的文献

1
The Environmental Impact of Medical Imaging Agents and the Roadmap to Sustainable Medical Imaging.医学成像剂的环境影响与可持续医学成像路线图
Adv Sci (Weinh). 2025 Mar;12(9):e2404411. doi: 10.1002/advs.202404411. Epub 2025 Feb 4.
2
Detection of breast cancer lesions using APT weighted MRI: a systematic review.使用APT加权磁共振成像检测乳腺癌病变:一项系统综述
J Transl Med. 2025 Jan 31;23(1):141. doi: 10.1186/s12967-025-06153-7.
3
Synthetic MRI and amide proton transfer-weighted MRI for differentiating between benign and malignant sinonasal lesions.合成磁共振成像和酰胺质子转移加权磁共振成像用于鉴别良恶性鼻窦病变。
Eur Radiol. 2024 Oct;34(10):6820-6830. doi: 10.1007/s00330-024-10696-6. Epub 2024 Mar 16.
4
Image quality assessment and feasibility of three-dimensional amide proton transfer-weighted imaging for hepatocellular carcinoma.肝细胞癌三维酰胺质子转移加权成像的图像质量评估及可行性
Quant Imaging Med Surg. 2024 Feb 1;14(2):1778-1790. doi: 10.21037/qims-23-767. Epub 2024 Jan 23.
5
Label-Free Chemically and Molecularly Selective Magnetic Resonance Imaging.无标记化学和分子选择性磁共振成像
Chem Biomed Imaging. 2023 Apr 12;1(2):121-139. doi: 10.1021/cbmi.3c00019. eCollection 2023 May 22.
6
Amide proton transfer imaging for the determination of human papillomavirus status in patients with oropharyngeal squamous cell carcinoma.酰胺质子转移成像用于检测口咽鳞状细胞癌患者的人乳头瘤病毒状态。
Medicine (Baltimore). 2022 Jul 15;101(28):e29457. doi: 10.1097/MD.0000000000029457.
7
Baseline Amide Proton Transfer Imaging at 3T Fails to Predict Early Response to Induction Chemotherapy in Nasopharyngeal Carcinoma.3T场强下的基线酰胺质子转移成像无法预测鼻咽癌诱导化疗的早期反应。
Front Oncol. 2022 Feb 8;12:822756. doi: 10.3389/fonc.2022.822756. eCollection 2022.
8
A Brief History and Future Prospects of CEST MRI in Clinical Non-Brain Tumor Imaging.临床非脑部肿瘤成像中 CEST MRI 的简史与未来展望。
Int J Mol Sci. 2021 Oct 26;22(21):11559. doi: 10.3390/ijms222111559.
9
Feasibility evaluation of amide proton transfer-weighted imaging in the parotid glands: a strategy to recognize artifacts and measure APT value.腮腺中酰胺质子转移加权成像的可行性评估:识别伪影和测量APT值的策略。
Quant Imaging Med Surg. 2021 Jun;11(6):2279-2291. doi: 10.21037/qims-20-675.
10
Differentiating malignant from benign salivary gland lesions: a multiparametric non-contrast MR imaging approach.鉴别良恶性涎腺病变:一种多参数非对比磁共振成像方法。
Sci Rep. 2021 Feb 2;11(1):2780. doi: 10.1038/s41598-021-82455-2.

本文引用的文献

1
CEST-Dixon for human breast lesion characterization at 3 T: A preliminary study.CEST-Dixon 用于 3T 下人体乳腺病变特征分析:一项初步研究。
Magn Reson Med. 2018 Sep;80(3):895-903. doi: 10.1002/mrm.27079. Epub 2018 Jan 10.
2
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
3
Improved Differentiation of Low-Grade and High-Grade Gliomas and Detection of Tumor Proliferation Using APT Contrast Fitted from Z-Spectrum.基于 Z 谱拟合的 APT 对比剂在低级别和高级别胶质瘤鉴别及肿瘤增殖检测中的应用
Mol Imaging Biol. 2018 Aug;20(4):623-631. doi: 10.1007/s11307-017-1154-y.
4
PET/MR Imaging in Head and Neck Cancer: Current Applications and Future Directions.头颈部癌的PET/MR成像:当前应用与未来方向
Magn Reson Imaging Clin N Am. 2018 Feb;26(1):167-178. doi: 10.1016/j.mric.2017.08.010. Epub 2017 Oct 21.
5
Applying Amide Proton Transfer MR Imaging to Hybrid Brain PET/MR: Concordance with Gadolinium Enhancement and Added Value to [F]FDG PET.应用酰胺质子转移磁共振成像于脑 PET/MR 融合:与钆增强的一致性和对 [F]FDG PET 的附加价值。
Mol Imaging Biol. 2018 Jun;20(3):473-481. doi: 10.1007/s11307-017-1136-0.
6
Amide proton transfer-weighted imaging to differentiate malignant from benign pulmonary lesions: Comparison with diffusion-weighted imaging and FDG-PET/CT.酰胺质子转移加权成像鉴别良恶性肺病变:与弥散加权成像和 FDG-PET/CT 的比较。
J Magn Reson Imaging. 2018 Apr;47(4):1013-1021. doi: 10.1002/jmri.25832. Epub 2017 Aug 11.
7
Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas.酰胺质子转移加权磁共振成像引导下的立体定向活检在新诊断胶质瘤患者中的应用
Eur J Cancer. 2017 Sep;83:9-18. doi: 10.1016/j.ejca.2017.06.009. Epub 2017 Jul 10.
8
Applying protein-based amide proton transfer MR imaging to distinguish solitary brain metastases from glioblastoma.应用基于蛋白的酰胺质子转移磁共振成像来区分单发脑转移瘤和胶质母细胞瘤。
Eur Radiol. 2017 Nov;27(11):4516-4524. doi: 10.1007/s00330-017-4867-z. Epub 2017 May 22.
9
Amide proton transfer CEST of the cervical spinal cord in multiple sclerosis patients at 3T.3T 下多发性硬化症患者颈脊髓酰胺质子转移 CEST。
Magn Reson Med. 2018 Feb;79(2):806-814. doi: 10.1002/mrm.26736. Epub 2017 May 5.
10
Evolution of Cerebral Ischemia Assessed by Amide Proton Transfer-Weighted MRI.通过酰胺质子转移加权磁共振成像评估的脑缺血演变
Front Neurol. 2017 Mar 2;8:67. doi: 10.3389/fneur.2017.00067. eCollection 2017.